Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.7)
Index Copernicus  – 161.11; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2007, vol. 16, nr 6, November-December, p. 817–818

Publication type: letter to editor

Language: English

Hereditary Spherocytosis Characterized by Decreased Spectrin/Band−3 Ratio

Dziedziczna sferocytoza związana z obniżonym stosunkiem spektryny/białka pasma 3

Jolanta Kłopocka1,

1 Department of Biophysics, Medical Centre of Postgraduate Education, Warszawa, Poland

References (6)

  1. Cutillo S, Pinto L, Nobili B, Miraglia del Giudice E, Iolascon A: Spectrin/band 3 ratio as diagnostic tool in hereditary spherocytosis. Eur J Pediatr 1992, 151, 35–37.
  2. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T 4. Nature. 1970, 227, 680–685.
  3. Pacuszka T, Panasiewicz M: Photochemical labeling of human erythrocyte membranes with radioiodinatable azidosalicylic acid derivative of globoside. Biochim Biophys Acta 1995, 1257, 256–273.
  4. Gallager PG, Forget BG: Sperctrin genes in health and disease. Semin Hematol 1993, 30, 1, 4–21.
  5. Eber S, Lux SE: Hereditary spherocytosis – defects in protein that connect the membrane skeleton to the lipid bilayer. Semin Hematol 2004, 41, 2, 118–141.
  6. Hassoun JN, Vassiliadis JN, Murray J, Najstad PR, Rogus JJ, Ballas SK, Schaffer F, Jarolim P: Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency. Blood 1997, 90, 1, 398–406.
© Wroclaw Medical University